Gene A. Gibson

643 total citations
22 papers, 505 citations indexed

About

Gene A. Gibson is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Gene A. Gibson has authored 22 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 5 papers in Geriatrics and Gerontology and 3 papers in Pharmacology. Recurrent topics in Gene A. Gibson's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (3 papers) and Patient Safety and Medication Errors (2 papers). Gene A. Gibson is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (3 papers) and Patient Safety and Medication Errors (2 papers). Gene A. Gibson collaborates with scholars based in United States and United Kingdom. Gene A. Gibson's co-authors include Mark G. Weiner, Robert Gross, Neil O. Fishman, Amy S. Morgan, Gary Milkovich, Robert A. Blouin, Larry A. Bauer, Ward O. Griffen, R. Jake Jacobs and Francis E. Marchlinski and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gene A. Gibson

21 papers receiving 476 citations

Peers

Countries citing papers authored by Gene A. Gibson

Since Specialization

Citations

This map shows the geographic impact of Gene A. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene A. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene A. Gibson more than expected).

Fields of papers citing papers by Gene A. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene A. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene A. Gibson. The network helps show where Gene A. Gibson may publish in the future.

Co-authorship network of co-authors of Gene A. Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Gene A. Gibson. A scholar is included among the top collaborators of Gene A. Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene A. Gibson. Gene A. Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Medical Resident–Pharmacist Collaboration Improves the Rate of Medication Reconciliation Verification at Discharge 2015 ·The Joint Commission Journal on Quality and Patient Safety ·Daniel A. Caroff, Therese Bittermann, Charles E. Leonard, Gene A. Gibson, Jennifer S. Myers	7
2	Improving Sepsis Care Through Systems Change: The Impact of a Medical Emergency Team 2008 ·The Joint Commission Journal on Quality and Patient Safety ·Babak Sarani, (unknown), Brandon Gabel, Jennifer S. Myers, Gene A. Gibson, (unknown), Barry D. Fuchs	12
3	Cost-Effectiveness of Hepatitis A–B Vaccine Versus Hepatitis B Vaccine for Healthcare and Public Safety Workers in the Western United States 2004 ·Infection Control and Hospital Epidemiology ·R. Jake Jacobs, Gene A. Gibson, Allen S. Meyerhoff	16
4	Considerations in Darbepoetin alfa Cost and Reimbursement: A Model for Pharmacy Managers 2003 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Gene A. Gibson	11
5	Derivation of malignancy status from ICD-9 codes. 2003 ·PubMed ·Mark G. Weiner, (unknown), (unknown), (unknown), Gene A. Gibson, Alison W. Loren, Sean Hennessy	25
6	Economic impact of bleeding complications and the role of antithrombotic therapies in percutaneous coronary intervention 2003 ·American Journal of Health-System Pharmacy ·Gary Milkovich, Gene A. Gibson	28
7	Information Systems Developments to Detect and Analyze Chemotherapy-associated Adverse Drug Events 2002 ·American Medical Informatics Association Annual Symposium ·Mark G. Weiner, (unknown), (unknown), (unknown), Gene A. Gibson, Alison W. Loren, Sean Hennessy	1
8	Impact of a Hospital‐Based Antimicrobial Management Program on Clinical and Economic Outcomes 2001 ·Clinical Infectious Diseases ·Robert Gross, Amy S. Morgan, (unknown), Mark G. Weiner, Gene A. Gibson, Neil O. Fishman	188
9	Comparative Safety of Filgrastim versus Sargramostim in Patients Receiving Myelosuppressive Chemotherapy 2000 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Gary Milkovich, (unknown), (unknown), (unknown), Gene A. Gibson, (unknown), (unknown), R. Jake Jacobs	17
10	Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case 1999 ·Pharmacoepidemiology and Drug Safety ·Brian L. Strom, Rita Schinnar, Gene A. Gibson, Patrick J. Brennan, Jesse A. Berlin	25
11	Cost minimization analysis of milrinone vs dobutamine treatment strategies as a bridge to heart transplant 1999 ·Journal of Cardiac Failure ·Eric J. Stanek, (unknown), Evan Loh, David DeNofrio, Gene A. Gibson	2
12	Economic Impact of a Drug Information Service 1999 ·Annals of Pharmacotherapy ·(unknown), (unknown), (unknown), Gene A. Gibson	34
13	A Systematic integrated approach to improvement of drug prescribing in an acute care hospital: A potential model for applied hospital pharmacoepidemiology 1993 ·Clinical Pharmacology & Therapeutics ·Brian L. Strom, Gene A. Gibson	7
14	Lack of Probenecid Effect on Nonrenal Excretion of Ceftriaxone in Anephric Patients 1990 ·The Journal of Clinical Pharmacology ·Indravadan H. Patel, (unknown), John J. Carbone, (unknown), Gail Morrison, Gene A. Gibson	2
15	Comparison of Gentamicin Immunoassays Using Univariate and Multivariate Analyses 1989 ·Therapeutic Drug Monitoring ·Eric G. Boyce, (unknown), Gene A. Gibson, Irving Nachamkin	5
16	Creatinine clearance estimation in protein-malnourished patients. 1989 ·PubMed ·Eric G. Boyce, Roland N. Dickerson, Gerard F. Cooney, Gene A. Gibson, J L Mullen	8
17	Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects 1987 ·The American Journal of Medicine ·(unknown), Belinda Flores, Yi‐Ju Li, Gene A. Gibson, Mark E. Josephson, Francis E. Marchlinski	36
18	Influence of High-Dose Pentobarbital on Theophylline Pharmacokinetics 1985 ·Therapeutic Drug Monitoring ·Gene A. Gibson, Robert A. Blouin, Larry A. Bauer, Robert P. Rapp, Phillip A. Tibbs	5
19	Naloxone‐Responsive Hypotension in a Patient with an ACTH‐Secreting Tumor 1983 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Brian L. Strom, Gene A. Gibson, Elliot S. Barnathan, Neil L. Coplan	3
20	Obtaining reimbursement for clinical pharmacokinetic monitoring. 1982 ·PubMed ·William N. Kelly, Gene A. Gibson, Douglas E. Miller	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact